由于Mounjaro减肥需求的激增, 英国的全科医生报告说工作量增加. UK GPs report rising workloads due to surge in Mounjaro demand for weight loss.

英国各地的全科医生报告说,由于病人对最初为2型糖尿病研制的减重药物Mounjaro的需求量增加,工作量大幅增加。 General practitioners across the UK are reporting a significant rise in workload due to increasing patient demand for Mounjaro, a weight-loss medication originally developed for type 2 diabetes. 许多病人正在寻求药物,以达到抑制食欲和减重的效果,从而导致延长预约时间、增加行政要求和在获取处方方面出现挑战。 Many patients are seeking the drug for its appetite-suppressing and weight-reducing effects, leading to longer appointment times, greater administrative demands, and challenges in securing prescriptions. GPs对可持续性表示关切,指出请求数量大,资源本已有限,可能影响对其他条件的照顾。 GPs express concern over sustainability, noting that the high volume of requests strains already limited resources and may impact care for other conditions.